Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer

Journal of Surgical Research

Volumn 101, Issue 2, 2001, Pages 242-247

  Sasaki, Hidefumi ^a   Yukiue, Haruhiro ^a   Moiriyama, Satoru ^a   Kobayashi, Yoshihiro ^a   Nakashima, Yoshiaki ^a   Kaji, Masahiro ^a   Kiriyama, Masanobu ^a   Fukai, Ichiro ^a   Yamakawa, Yosuke ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Ets 1; Invasion; LightCycler; Lung cancer; Metastasis; MMP 7

Indexed keywords

MATRILYSIN; MESSENGER RNA; TRANSCRIPTION FACTOR ETS 1;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CORRELATION ANALYSIS; DEVICE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

EID: 0035671865     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2001.6279     Document Type: Article

References (31)

1. Cancer of the lung
2. On behalf of the Japanese Association for Thoracic Surgery: Thoracic and cardiovascular surgery in Japan during 1998. Annual report by the Japanese association for thoracic surgery
3. On behalf of the Lung Cancer Cooperative Group of the EORTC. The experience of the lung cancer cooperative group of the European Organization for Research and Treatment of Cancer
4. Critical factors in the biology of human cancer metastasis: Twenty-eight G.H.A. Clows Memorial Award Lecture
5. The pathogenesis of cancer metastasis
6. Matrix metalloproteinases in tumor invasion and metastasis
7. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
8. Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas
9. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma
10. Matrix metalloproteinase-7 expression in gastric carcinoma
11. Mechanism controlling transcription of matrix metalloproteinase genes in normal and neoplastic cells
12. Regulation of matrix metalloproteinase expression in tumor invasion
13. The Ets family of transcription factors
14. The ETS-domain transcription family
15. Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors
16. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins
17. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma
18. The LightCycler: A microplume multisample fluorimeter with rapid temperature control
19. Matrix metalloproteinase degradation of elastin, type IV collagen, and proteoglycan: A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysin-1 and -2 and punctuated metalloproteinase (PUMP)
20. Tumor cell interactions with the extracellular matrix during invasion and metastasis
21. Structural biochemistry and activation of matrix mettalloproteases
22. Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers
23. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo
24. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
25. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin
26. Expression and localization of matrix metalloproteinase-7 (matrilysin) in human gastric carcinomas
27. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymatic properties
28. Association of matrilysin expression with recurrence and poor prognosis in human esophageal carcinoma
29. The metalloproteinase matrilysin is a target of beta-catenin trans-activation in intestinal tumors
30. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer